Goldline Pharmaceutical IPO
Goldline Pharmaceutical IPO details, GMP, subscription, price band, allotment and listing information.
Final Subscription
781.85xFinal subscription figures
QIB
—
NII
—
Retail
—
Listing Performance
Issue Price
43
Listing Price
59.75
Goldline Pharmaceutical IPO Details
Price Band
41-43
Issue Price
43
Lot Size
3000
Issue Size
12
Open Date
12-05-2026
Close Date
14-05-2026
Allotment Date
15-05-2026
Listing Date
19-05-2026
Listing On
—
Registrar
—
Subscription
781.85xQIB
—
NII
—
Retail
—
Important Dates
IPO Opens
12-05-2026
IPO Closes
14-05-2026
Allotment
15-05-2026
Listing
19-05-2026
Goldline Pharmaceutical IPO
Goldline Pharmaceutical is a SME IPO available on the exchange. The IPO has a price band of 41-43 and an issue size of 12. Investors can check the lot size, IPO dates, subscription details and listing information on The IPO Hub.
This page provides information about the Goldline Pharmaceutical IPO, including its price, subscription status, allotment date, listing date and other important IPO details. For open IPOs, the current GMP is also displayed when available.
GMP is an unofficial market indicator and may change frequently. It should not be considered guaranteed listing performance or investment advice.